Jiménez-Villanueva X, Martínez-Alaniz D, Sosa-Durán EE, Aboharp-Hasan Z, Cortés-Gutiérrez ME, Rovelo-Lima JE

Language: Spanish
References: 10
Page: 5-7
PDF size: 133.83 Kb.

ABSTRACT

Neuroendocrine tumors originate from the diffuse neuroendocrine system, located in the different organs of the human body; thus, these neoplasms can affect any anatomical site. Neuroendocrine tumors form a large and heterogeneous group of malignant neoplasms with different biological behaviors, they represent less than 1% of all neoplasms and are most frequently located in the gastroenteropancreatic system, their location in the mammary gland is unusual. Our objective is to present the experience with four clinical cases in the Oncology Unit of the Hospital Juárez de México.

REFERENCES

1. Hallet J, Law CH, Cukier M, Saskin R, Liu N, Singh S. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes. Cancer 2015; 121(4): 589-97.

2. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008; 26(18): 3063-72.

3. Tajima S, Horiuchi H. Neuroendocrine tumor, well differentiated, of the breast: a relatively high-grade case in the histological subtype. Case Rep Pathol 2013; 2013: 204065.

4. Tavassoli FA, Devilee P. Pathology and genetics. In: Tumors of the breast and female genital organs. WHO classification of tumors series. Lyon: IARC Press; 2003. p. 32-4.

5. Cubilla AL, Woodruff JM. Primary carcinoid tumor of the breast: a report of eight patients. Am J Surg Pathol 1977; 1(4): 283-92.

6. Feki J, Fourati N, Mnif H, Khabir A, Toumi N, Khanfir A, et al. Primary neuroendocrine tumors of the breast: a retrospective study of 21 cases and literature review. Cancer Radiother 2015; 19(5): 308-12.

7. Herrera-Torres A, García-Rodríguez FM, Gil GR, Jiménez-Villanueva X, Hernández-Rubio Á, Aboharp-Hasan Z. Frecuencia de cáncer en un hospital de tercer nivel de la Ciudad de México. Implicaciones para el desarrollo de métodos de detección oportuna. Cir Cir 2014; 82(1): 28-37.

8. Wang J, Wei B, Albarracin CT, Hu J, Abraham SC, Wu Y. Invasive neuroendocrine carcinoma of the breast: a population-based study from the surveillance, epidemiology and end results(SEER) database. BMC Cancer 2014; 14: 147.

9. Park YM, Wu Y, Wei W, Yang WT. Primary neuroendocrine carcinoma of the breast: clinical, imaging, and histologic features. AJR Am J Roentgenol 2014; 203(2): W221-30.

10. Inno A, Bogina G, Turazza M, Bortesi L, Duranti S, Massocco A, et al. Neuroendocrine carcinoma of the breast: current evidence and future perspectives. Oncologist 2016; 21(1): 28-32.